MiR-182-5p within BMMSC-EVs can reduce inflammation and enhance heart function after MI by suppressing the TLR4/nuclear transcription factor-κB (NF-κB) signaling pathway (119) (Figure 3). The gene discussed is TLR4; the disease is myocardial infarction.